jimmy Turano: MRNA-THREE YEARS OF DECLINE, NO EXPENSE MONEY AS OF YET FOR 2010, WARNING OF COMPLIANCE, DEADLINE FEBRUARY, WHEN YEAR END EARNINGS DO OUT!
jimmy Turano: 'MRNA' YEAR END REVIEW. READ TOPIX.COM, BIOTECH, 'MRNA' FOR COMPLETE REVIEW! 25-40% FURTHER DOWNWARD OR $4 LIKE RESEARCH FIRMS STATE? DA!
jimmy Turano: NOT INVESTING WITH CURRENT DOW LEVELS, ESPECIALLY WITH UNCERTAINTY, & YEAR END SELLING COMING. SPEAKING OF UNCERTAINTY, 'MRNA' IS A ? $.93